Compounded GLP-1s Are Not FDA-Approved Jorge Moreno, MD, an assistant professor and obesity medicine doctor at Yale Medicine in New Haven, Connecticut, says the findings highlight a broader concern that obesity specialists have about compounded versions of GLP-1 medications
PMC 5861502
From GLP-1s, adrenal treatments, and acromegaly breakthroughs to obesity, diabetes, and cutting-edge research in reproductive medicine, 2025 was a banner year for endocrine research and researchers
GSH , , ,
When looking at semaglutide by specific mental illnesses, it was found to lower the risk of worsening depression by 44%, anxiety disorders by 38%, and substance use disorders by 47%
Spoiled as ever, the cats wont even need to receive regularly injections of the drug